Is Idorsia the next biotech winner in Europe? The founders have sold their previous company for $30B in cash They now want to do it again, and hold 29% of Idorsia Their insomnia drug has just been approved in the US Idorsia is a high-potential Swiss biotech company, founded by the same people that built…